SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-015739
Filing Date
2024-04-24
Accepted
2024-04-23 20:47:34
Documents
62
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 1515565
2 ex32-1.htm EX-32.1 8050
3 form10-k_001.jpg GRAPHIC 22820
4 form10-k_002.jpg GRAPHIC 12061
5 form10-k_003.jpg GRAPHIC 20362
6 form10-k_004.jpg GRAPHIC 17245
  Complete submission text file 0001493152-24-015739.txt   5524512

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ptix-20231231.xsd EX-101.SCH 34612
8 XBRL CALCULATION FILE ptix-20231231_cal.xml EX-101.CAL 46708
9 XBRL DEFINITION FILE ptix-20231231_def.xml EX-101.DEF 180874
10 XBRL LABEL FILE ptix-20231231_lab.xml EX-101.LAB 355513
11 XBRL PRESENTATION FILE ptix-20231231_pre.xml EX-101.PRE 278875
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 581723
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12555 | Film No.: 24866512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)